Astria Therapeutics Analyst Ratings
BenzingaMar 25 12:34 ET
Astria Therapeutics Analyst Ratings
BenzingaMar 14 07:11 ET
Astria Therapeutics Analyst Ratings
BenzingaMar 5 07:02 ET
Astria Therapeutics Analyst Ratings
BenzingaJan 30 11:01 ET
Astria Therapeutics Analyst Ratings
BenzingaNov 15, 2023 13:10 ET
Oppenheimer Adjusts Astria Therapeutics Price Target to $25 From $30, Maintains Outperform Rating
MT NewswiresNov 15, 2023 09:12 ET
Wedbush Trims Astria Therapeutics' Price Target to $17 From $18, Keeps Outperform Rating
MT NewswiresNov 13, 2023 12:01 ET
Wedbush Maintains Outperform on Astria Therapeutics, Lowers Price Target to $18
BenzingaOct 13, 2023 11:22 ET
Astria Therapeutics Analyst Ratings
BenzingaOct 13, 2023 11:21 ET
HC Wainwright & Co. Maintains Buy on Astria Therapeutics, Lowers Price Target to $18
BenzingaOct 12, 2023 07:06 ET
Astria Therapeutics Analyst Ratings
BenzingaOct 12, 2023 07:02 ET
Wedbush Trims Astria Therapeutics' Price Target to $25 From $26, Keeps Outperform Rating
MT NewswiresAug 8, 2023 07:09 ET
Astria Therapeutics Analyst Ratings
BenzingaAug 8, 2023 06:30 ET
Oppenheimer Reiterates Outperform on Astria Therapeutics, Maintains $30 Price Target
BenzingaJun 8, 2023 07:52 ET
HC Wainwright & Co. Reiterates Buy on Astria Therapeutics, Maintains $20 Price Target
BenzingaMay 12, 2023 06:30 ET
Evercore ISI Group Initiates Coverage On Astria Therapeutics With Outperform Rating, Announces Price Target of $18
BenzingaMar 28, 2023 07:12 ET
Wedbush Adjusts Price Target on Astria Therapeutics to $26 From $27, Keeps Outperform Rating
MT NewswiresMar 22, 2023 10:57 ET
HC Wainwright & Co. Reiterates Buy on Astria Therapeutics, Maintains $20 Price Target
BenzingaFeb 24, 2023 12:57 ET
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
Benzinga Real-time NewsDec 19, 2022 08:31 ET
Astria Therapeutics Analyst Ratings
Benzinga Analyst RatingsDec 19, 2022 06:14 ET
No Data
No Data